指南与共识脑血管病

缺血性卒中血管内治疗的性别差异:来自Get With The Guidelines-Stroke登记研究的结果

Sex Differences in Endovascular Therapy for Ischemic Stroke: Results From the Get With The Guidelines-Stroke Registry.
指南 / 共识 · Stroke · 2022-07-26

该研究基于Get With The Guidelines-Stroke登记库,纳入2012至2019年符合血管内治疗(EVT)潜在条件的急性缺血性卒中患者302965例,其中42422例(14%)接受了EVT。结果显示,2015年前女性EVT使用率低于男性,2015年后两性使用率均大幅上升且差异不再显著;EVT后女性出院时活动能力更差但院内死亡率更低。

要点

  • 2015年前女性EVT使用率5.3% vs 男性6.6%,校正OR 0.93(95%CI 0.87-0.99)。
  • 2015至2019年女性EVT使用率16.7% vs 男性18.5%,校正OR 0.98(95%CI 0.96-1.01)。
  • 2015年后女性出院时活动能力更差(校正OR 0.95,95%CI 0.95-0.99),院内死亡率更低(校正OR 0.93,95%CI 0.88-0.99)。

核心结论

  • 自2015年EVT获批后,女性和男性EVT使用率均大幅上升;校正后女性初始EVT使用可能性较低,但2015年后女性接受EVT的可能性与男性相当。
  • EVT后女性出院时残疾的可能性更高,但发生院内死亡的可能性低于男性。

研究设计与样本

  • 研究为基于Get With The Guidelines-Stroke登记库的分析,纳入2012至2019年急性缺血性卒中出院患者。
  • 潜在符合EVT的条件为美国国立卫生研究院卒中量表(NIHSS)评分≥6分且到达时间<6小时,依据2018年美国心脏协会/美国卒中协会(AHA/ASA)指南。
  • 共纳入302965例潜在符合EVT的患者,其中42422例(14%)接受了EVT。
  • 采用多变量回归分析评估性别与EVT使用及EVT后结局的关联,并分2012至2014年和2015至2019年两个时间段分别分析。

主要发现

  • 2015年前,女性EVT治疗率为5.3%,男性为6.6%。
  • 2015至2019年,两性治疗率均上升,女性为16.7%,男性为18.5%。
  • 女性相比男性接受EVT的校正比值比在2015年前为0.93(95%CI 0.87-0.99),2015年后为0.98(95%CI 0.96-1.01)。
  • 除2015年后女性出院时活动能力更差(校正比值比0.95,95%CI 0.95-0.99)和院内死亡率更低(校正比值比0.93,95%CI 0.88-0.99)外,结局无显著性别差异。

关键数值与推荐

  • 潜在符合EVT的条件:NIHSS评分≥6分且到达时间<6小时,依据2018年AHA/ASA指南。
  • 2015年前女性EVT率5.3% vs 男性6.6%,校正OR 0.93(95%CI 0.87-0.99)。
  • 2015至2019年女性EVT率16.7% vs 男性18.5%,校正OR 0.98(95%CI 0.96-1.01)。
  • 2015年后女性出院时活动能力校正OR 0.95(95%CI 0.95-0.99),院内死亡校正OR 0.93(95%CI 0.88-0.99)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2015, endovascular therapy (EVT) for large vessel occlusions became standard of care for acute ischemic stroke. Lower utilization of IV alteplase has been reported in women, but whether sex differences in EVT use in the United States exists has not been established. METHODS: We identified all acute ischemic stroke discharges from Get With The Guidelines-Stroke hospitals between 2012 and 2019 who were potentially eligible for EVT, based on National Institutes of Health Stroke Scale score ≥6 and arrival <6 hours, according to 2018 American Heart Association/ASA guidelines. Multivariable regression analyses were used to determine the association between sex and EVT utilization, and outcomes (including mortality, discharge home, functional status) after EVT. Separate analyses were conducted for the 2 time periods: 2012 to 2014, and 2015 to 2019. RESULTS: Of 302 965 patients potentially eligible for EVT, 42 422 (14%) received EVT. Before 2015, EVT treatment rates were 5.3% in women and 6.6% in men. From 2015 to 2019, treatment rates increased in both sexes to 16.7% in women and 18.5% in men. The adjusted odds ratio for EVT in women compared with men was 0.93 (95% CI, 0.87-0.99) before 2015, and 0.98 (95% CI, 0.96-1.01) after 2015. There were no significant sex differences in outcomes except that after 2015, women were less able to ambulate at discharge (adjusted odds ratio, 0.95 [95% CI, 0.95-0.99]) and had lower in-hospital mortality (adjusted odds ratio, 0.93 [95% CI, 0.88-0.99]). CONCLUSIONS: EVT utilization has increased dramatically in both women and men since EVT approval in 2015. Following statistical adjustment, women were less likely to receive EVT initially, but after 2015, women were as likely as men to receive EVT. After EVT, women were more likely to be disabled at discharge but less likely to experience in-hospital death compared with men.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Demel SL, Reeves M, Xu H, et al. Sex Differences in Endovascular Therapy for Ischemic Stroke: Results From the Get With The Guidelines-Stroke Registry. Stroke. 2022. PMID: 35880521. doi:10.1161/STROKEAHA.122.038491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。